Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Comparative Analysis of the LOBO Device and Coils for Proximal Splenic Artery Embolization: A Multi-Institutional Retrospective Study.
Journal: Cardiovascular and interventional radiology
Published: January 20, 2026
High-Specific-Activity Resin Yttrium-90 Radiation Segmentectomy of Hepatocellular Carcinoma: A Study of Efficacy, Safety, and Dosimetry Considerations.
Journal: Cardiovascular and interventional radiology
Published: November 25, 2025
Radioembolization in Hepatocellular Carcinoma: Indications and Outcomes.
Journal: Journal of gastrointestinal cancer
Published: November 03, 2025
Early Experience Using Tantalum-Loaded Nanocomposite Hydrogel Conformable Embolic for Upper Gastrointestinal Bleeding-Open-Sandwich Technique.
Journal: Journal of clinical medicine
Published: February 19, 2025
Technical and Clinical Outcomes of Embolization of Hypervascular Renal Tumors Using Tantalum-Loaded Obsidio Conformable Embolic (Ta-OCE): a single-center experience.
Journal: CVIR oncology
Published: January 01, 2025
Thoracic Duct Embolization with a Shear-Thinning Nanocomposite Hydrogel.
Journal: Journal of vascular and interventional radiology : JVIR
Published: October 19, 2024
Resin-Based 90 Y Tumor Dose as a Predictor of Duration of Response and Survival in Patients With Surgically Unresectable Hepatocellular Carcinoma : A Prospective Single-Arm Study.
Journal: Clinical nuclear medicine
Published: June 11, 2024
Cytological diagnosis of follicular dendritic cell sarcoma with a unique pattern of D2-40 immunoexpression.
Journal: Diagnostic cytopathology
Published: March 21, 2024
Yttrium-90 Radioembolization Dosimetry: Dose Considerations, Optimization, and Tips.
Journal: Seminars in interventional radiology
Published: March 18, 2024
Impact of Hypoxia on Radiation-Based Therapies for Liver Cancer.
Journal: Cancers
Published: January 04, 2024
Safety and Efficacy of Concurrent Atezolizumab/Bevacizumab or Nivolumab Combination Therapy with Yttrium-90 Radioembolization of Advanced Unresectable Hepatocellular Carcinoma.
Journal: Current oncology (Toronto, Ont.)
Published: October 01, 2023
Authors' Reply: Short- and Long-Term Outcomes for Resin-Based Yttrium-90 Radiation Segmentectomy of Hepatocellular Carcinoma Should Be Further Investigated.
Journal: Journal of vascular and interventional radiology : JVIR
Published: June 04, 2023
Last Updated: 09/26/2026